<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Improvement of energy metabolism in ischemic cerebral tissue benefits the therapy of occlusive cerebrovascular disorders </plain></SENT>
<SENT sid="1" pm="."><plain>In the present study, the effects of 6-(10-hydroxydecyl)-2,3-dimethoxy-5-<z:chebi fb="36" ids="29309">methyl</z:chebi>-1,4-<z:chebi fb="0" ids="16509,39439">benzoquinone</z:chebi> (idebenone) on neurological signs, such as ischemic <z:hpo ids='HP_0001250'>seizures</z:hpo>, <z:chebi fb="4" ids="24996">lactate</z:chebi> and ATP contents of the cerebral cortex, and local cerebral blood flow, were assessed in <z:hpo ids='HP_0001297'>stroke</z:hpo>-prone spontaneously hypertensive rats (SHRSP) with experimentally induced <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Experimental <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> was caused by bilateral carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> (BCAO) in male SHRSP (8-10 weeks old) </plain></SENT>
<SENT sid="3" pm="."><plain>Pretreatment with idebenone (10-100 mg/kg, p.o.) for 3 or 10 days delayed the <z:hpo ids='HP_0003674'>onset</z:hpo> of ischemic <z:hpo ids='HP_0001250'>seizure</z:hpo> (<z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0001297'>stroke</z:hpo>) and prolonged survival time in SHRSP roughly in a dose-dependent manner </plain></SENT>
<SENT sid="4" pm="."><plain>When the compound (100 mg/kg, i.p.) was given once 30 min after BCAO, it exerted similar ameliorating effects on the neurological deficits </plain></SENT>
<SENT sid="5" pm="."><plain>When idebenone (100 mg/kg for 3 days) was given orally, it did not significantly inhibit the decrease in regional cerebral blood flow induced by BCAO </plain></SENT>
<SENT sid="6" pm="."><plain>However, the same treatment markedly inhibited increases in the <z:chebi fb="4" ids="24996">lactate</z:chebi> content and <z:chebi fb="4" ids="24996">lactate</z:chebi>/<z:chebi fb="1" ids="15361">pyruvate</z:chebi> ratio and the decrease in ATP content of the cerebral cortex </plain></SENT>
<SENT sid="7" pm="."><plain>The compound did not affect cerebral blood flow in <z:mpath ids='MPATH_458'>normal</z:mpath> rats </plain></SENT>
<SENT sid="8" pm="."><plain>These results suggest that idebenone ameliorates the neurological deficits related to <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>, and that this effect is mediated by improving cerebral energy metabolism </plain></SENT>
</text></document>